Biologics distribution for orthopedic surgery centers in Cleveland

Shipping and receiving across multiple sites

A multi-site orthopedic group in the Cleveland area often routes Wharton's jelly and exosome orders through a single purchasing contact even when product is received at more than one surgery center or clinic location. Cryopreserved products ship overnight on dry ice in validated containers and are stored at -80 degrees Celsius prior to shipment, so each receiving location needs a process for checking the cold-chain indicator on arrival regardless of which site placed the order. Lyophilized formats do not require cryogenic storage and are handled according to the insert that accompanies the lot.

Every lot carries a unique identifier, and Precision Biologics expects clinics to track use of the product by lot at the patient record level for traceability, which matters more, not less, when a group is receiving shipments at several addresses.

Documentation for a surgery center's compliance file

Surgery centers typically keep a compliance file on every tissue and biologic product they stock, and a new vendor is expected to supply the certificate of analysis, donor eligibility summary, and lot release record for that file before the first order. Wharton's jelly allografts and exosome products are documented separately because they sit under different parts of the federal regulatory framework; Precision Biologics makes both sets of documentation available to verified accounts.

NPI-verified ordering

Accounts are opened only for licensed professionals and require a valid NPI number before pricing or ordering access is released. A Cleveland orthopedic practice or surgery center supplies that information during onboarding, and the account is matched against the NPI record rather than against a general business listing.

Confirming standing before adding a product line

Precision Biologics does not advise on clinical use, dosing, or surgical technique, and recommends that a Cleveland practice confirm its own standing with the Ohio medical board and review the regulatory posture of any Wharton's jelly or exosome product with its own counsel before purchasing. Precision Biologics supports account setup with licensure and lot documentation on request and with physician-level calls limited to product documentation.

These products are not FDA approved or licensed for any disease or condition. Information here is for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.